menu

CME: Pediatric Asthma: Evidence-Based Approaches in Poorly-Controlled Disease

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Pediatric Asthma: Evidence-Based Approaches in Poorly-Controlled Disease

close
0.50 credits
30 minutes
Pediatric Asthma: Evidence-Based Approaches in Poorly-Controlled Disease
Restart
Resume
Read full article
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
Details
Presenters
Related
Comments
  • Overview

    Activity date:
    1/30/2020 - 1/29/2021

    Asthma is one of the most common chronic diseases of childhood. While most children achieve asthma control, some develop severe and persistent disease that cannot be controlled with standard treatment options. Evolution in our understanding of asthma biology has led to the development of novel targeted therapies that target the underlying mechanisms of disease, several of which are now available for pediatric patients. This interactive activity combines artistic design, infographic presentation, and scientific expertise to deliver the latest advances in treatment of pediatric asthma, including current treatment guidelines, identifying poorly-controlled disease, and incorporating novel biologic therapy into the management of pediatric patients with asthma.

  • Faculty

    Michael E. Wechsler, MD, MMSc   
    Professor of Medicine
    Director, Cohen Family NJH Asthma Institute
    Director, Asthma Program, National Jewish Health
    Division of Pulmonary, Critical Care and Sleep Medicine
    Department of Medicine
    National Jewish Health and University of Colorado School of Medicine
    Aurora, CO

  • Target Audience

    This activity is designed for allergy/immunology and pulmonology providers including physicians, nurse practitioners, and physician assistants who manage pediatric patients with asthma.  

  • Learning Objectives

    • Incorporate current recommended treatment algorithms into the care of pediatric patients with asthma  
    • Identify children with poorly-controlled asthma for whom treatment escalation may be appropriate  
    • Integrate newer and more effective treatments for children with resistant or moderate-to-severe asthma based on safety and efficacy data and different asthma endotypes  
  • Accreditation and Credit Designation Statements

    Physicians
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

    AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Physician Assistants
    NCCPA accepts AMA PRA Category 1 Credit(s) from organizations accredited by ACCME.

  • Provider(s)/Educational Partner(s)

    This educational activity was independently developed by RMEI Medical Education, LLC, in collaboration with Advancing Knowledge in Healthcare (AKH) Inc. 

  • Commercial Support

    This activity is supported by independent educational grants from Genentech and Sanofi Genzyme and Regeneron Pharmaceuticals.

  • Disclosure Declarations

    It is the policy of AKH Inc. and RMEI Medical Education, LLC to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.  AKH Inc. planners and reviewers have no relevant financial relationships to disclose.  

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

    Michael Wechsler, MD, MMSc has disclosed the following relevant financial relationships: AstraZeneca, Genentech, GlaxoSmithKline, Mylan, Novartis, Regeneron, Sanofi, Teva (Consultant); AstraZeneca, GlaxoSmithKline, Sanofi, Regeneron, Teva (Contracted Research).

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    RMEI Medical Education, LLC

    • Chelsey Goins, PhD, has no affiliations with commercial interests to disclose.
    • Lobna M. Eldasher, PharmD, has no affiliations with commercial interests to disclose.
    • Sharon Powell, has no affiliations with commercial interests to disclose. 

    AKH, Inc.

    • Dorothy Caputo, MA, BSN, RN, Director of Accreditation, Planner, has no affiliations with commercial interests to disclose. 
    • Patricia Brignoni, AKH Sr. Project Manager, has no affiliations with commercial interests to disclose. 

    Disclosure of Unlabeled Use
    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer
    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and RMEI Medical Education, LLC specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

  • How to Receive Your Credit

    By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and PAs are entitled to receive up to 0.5 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. 

     Users must: 

    • Read the learning objectives and faculty disclosures. 
    • Participate in the activity. 
    • Complete the activity post-test and evaluation. 

    Physicians, nurse practitioners, and PAs who successfully complete the post-test and evaluation will receive CME/CE credit. You must score 65% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation. If you have questions about this CE activity, please contact AKH Inc. at tbrignoni@akhcme.com

  • Your Feedback is Important to Us

    COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED
    INTO A DRAWING FOR A $100* AMAZON GIFT CARD!

    *The expense for this gift card is solely funded by RMEI Medical Education, LLC. No supporter funding was used for the expense of this gift card.

    Rules and Regulations 
    This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a full-service medical education company. The winner will be selected via automated random drawing on a monthly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.

  • Media

    Online, Web

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    Activity date:
    1/30/2020 - 1/29/2021

    Asthma is one of the most common chronic diseases of childhood. While most children achieve asthma control, some develop severe and persistent disease that cannot be controlled with standard treatment options. Evolution in our understanding of asthma biology has led to the development of novel targeted therapies that target the underlying mechanisms of disease, several of which are now available for pediatric patients. This interactive activity combines artistic design, infographic presentation, and scientific expertise to deliver the latest advances in treatment of pediatric asthma, including current treatment guidelines, identifying poorly-controlled disease, and incorporating novel biologic therapy into the management of pediatric patients with asthma.

  • Faculty

    Michael E. Wechsler, MD, MMSc   
    Professor of Medicine
    Director, Cohen Family NJH Asthma Institute
    Director, Asthma Program, National Jewish Health
    Division of Pulmonary, Critical Care and Sleep Medicine
    Department of Medicine
    National Jewish Health and University of Colorado School of Medicine
    Aurora, CO

  • Target Audience

    This activity is designed for allergy/immunology and pulmonology providers including physicians, nurse practitioners, and physician assistants who manage pediatric patients with asthma.  

  • Learning Objectives

    • Incorporate current recommended treatment algorithms into the care of pediatric patients with asthma  
    • Identify children with poorly-controlled asthma for whom treatment escalation may be appropriate  
    • Integrate newer and more effective treatments for children with resistant or moderate-to-severe asthma based on safety and efficacy data and different asthma endotypes  
  • Accreditation and Credit Designation Statements

    Physicians
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

    AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Physician Assistants
    NCCPA accepts AMA PRA Category 1 Credit(s) from organizations accredited by ACCME.

  • Provider(s)/Educational Partner(s)

    This educational activity was independently developed by RMEI Medical Education, LLC, in collaboration with Advancing Knowledge in Healthcare (AKH) Inc. 

  • Commercial Support

    This activity is supported by independent educational grants from Genentech and Sanofi Genzyme and Regeneron Pharmaceuticals.

  • Disclosure Declarations

    It is the policy of AKH Inc. and RMEI Medical Education, LLC to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.  AKH Inc. planners and reviewers have no relevant financial relationships to disclose.  

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

    Michael Wechsler, MD, MMSc has disclosed the following relevant financial relationships: AstraZeneca, Genentech, GlaxoSmithKline, Mylan, Novartis, Regeneron, Sanofi, Teva (Consultant); AstraZeneca, GlaxoSmithKline, Sanofi, Regeneron, Teva (Contracted Research).

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    RMEI Medical Education, LLC

    • Chelsey Goins, PhD, has no affiliations with commercial interests to disclose.
    • Lobna M. Eldasher, PharmD, has no affiliations with commercial interests to disclose.
    • Sharon Powell, has no affiliations with commercial interests to disclose. 

    AKH, Inc.

    • Dorothy Caputo, MA, BSN, RN, Director of Accreditation, Planner, has no affiliations with commercial interests to disclose. 
    • Patricia Brignoni, AKH Sr. Project Manager, has no affiliations with commercial interests to disclose. 

    Disclosure of Unlabeled Use
    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer
    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and RMEI Medical Education, LLC specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

  • How to Receive Your Credit

    By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and PAs are entitled to receive up to 0.5 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. 

     Users must: 

    • Read the learning objectives and faculty disclosures. 
    • Participate in the activity. 
    • Complete the activity post-test and evaluation. 

    Physicians, nurse practitioners, and PAs who successfully complete the post-test and evaluation will receive CME/CE credit. You must score 65% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation. If you have questions about this CE activity, please contact AKH Inc. at tbrignoni@akhcme.com

  • Your Feedback is Important to Us

    COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED
    INTO A DRAWING FOR A $100* AMAZON GIFT CARD!

    *The expense for this gift card is solely funded by RMEI Medical Education, LLC. No supporter funding was used for the expense of this gift card.

    Rules and Regulations 
    This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a full-service medical education company. The winner will be selected via automated random drawing on a monthly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.

  • Media

    Online, Web

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/24/20